Director of Research and Professor of Pathology, Dalhousie University
Graham Dellaire's expertise spans multiple disciplines including molecular and cellular biology, cancer biology, DNA repair and gene editing. He is also an expert in advanced light and electron microscopy techniques. Dr. Dellaire holds 1 US patent on gene targeting technology and has developed novel assays for correlative light and electron microscopy and for measuring CRISPR/Cas9 gene editing efficiency in human cells. He is also a guest editor of the journal Current Gene Therapy, and co-editor of the books "The Functional Nucleus" and "Cancer Genomics: from Bench to Personalized Medicine".
Formerly a Canadian Institutes of Health Research (CIHR) New Investigator, Dr. Dellaire is currently a Senior Scientist of the Beatrice Hunter Cancer Research Institute (BHCRI), Co-Chair of the Cancer Research Training Program (CRTP) and Director of Research in the Department of Pathology at Dalhousie University in Halifax, Canada. Work in his laboratory is focused on the underlying mechanisms of radiation and chemotherapy resistance in cancer, including dysregulation of DNA repair and alterations in the architecture of the cell nucleus.
Genetically modifying mosquitoes to control the spread of disease carries unknown risks
Oct 02, 2019 02:46 am UTC| Insights & Views Science
Every year, around one million people die of mosquito-borne diseases according to the World Health Organization (WHO). This is why mosquitoes are considered one of the deadliest living creatures on the planet not because...
Electricity from farm waste: how biogas could help Malawians with no power
What the Supreme Court is doing right in considering Trump’s immunity case
US election: why it’s not the protesters’ votes that the Democrats should worry about
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects